|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2006-11-19
|
|
pubmed:abstractText |
The efficacy and safety of switching to olanzapine were investigated in patients with first-episode schizophrenia who failed to attain an adequate clinical response to an initial therapeutic trial of risperidone (2-6 mg/day for 12 weeks).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1555-2101
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
67
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1577-82
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:17107250-Adolescent,
pubmed-meshheading:17107250-Adult,
pubmed-meshheading:17107250-Antipsychotic Agents,
pubmed-meshheading:17107250-Benzodiazepines,
pubmed-meshheading:17107250-Brief Psychiatric Rating Scale,
pubmed-meshheading:17107250-Cross-Over Studies,
pubmed-meshheading:17107250-Diagnostic and Statistical Manual of Mental Disorders,
pubmed-meshheading:17107250-Female,
pubmed-meshheading:17107250-Humans,
pubmed-meshheading:17107250-Male,
pubmed-meshheading:17107250-Prognosis,
pubmed-meshheading:17107250-Psychiatric Status Rating Scales,
pubmed-meshheading:17107250-Risperidone,
pubmed-meshheading:17107250-Schizophrenia,
pubmed-meshheading:17107250-Schizophrenic Psychology,
pubmed-meshheading:17107250-Severity of Illness Index,
pubmed-meshheading:17107250-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial.
|
|
pubmed:affiliation |
Yuri Kumiai General Hospital, Honjoh, Akita, Japan. takahashi_h1969@yahoo.co.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|
